OpenVSafe by OpenVAERS
Search V-safe

U3A-16294-52286

2 vaccinations 3 coded responses 9 check-ins 3 free-text entries 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
666 / KS
Registered
2021-01-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  3. 2021-01-11
    Registered in v-safe
  4. 2021-01-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling, Itching · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Itching · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-01-17
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-02-19
  13. 2021-04-09
    Survey response — 3 months, dose 2
    MedDRA: Exposure during pregnancy — Feeling: Good
    Free text: Pregnancy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-07-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2022-01-08
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-08Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-11

Systemic reaction (other): Lymphadenopathy

2021-01-12

Systemic reaction (other): Lymphadenopathy

Release 7 — 3 months, dose 2

2021-04-09

Symptoms: Pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDExposure during pregnancy ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release